Adding bortezomib ‘boosts acute myeloid leukemia chemotherapy response’

http://ifttt.com/images/no_image_card.png Older patients with untreated acute myeloid leukemia may benefit from having bortezomib added to daunorubicin and cytarabine during induction therapy and to consolidation intermediate-dose cytarabine, the results of a US study indicate.

Read more...